GUELPH, Canada

Heinz Werner Pauls

This inventor holds 1 USPTO granted patent. Top assignee: Canopy Growth Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinz Werner Pauls. Retrieved from https://idiyas.com/inventor/heinz-werner-pauls

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Heinz Werner Pauls in Cannabinoid Derivatives

Introduction

Heinz Werner Pauls is an accomplished inventor based in Guelph, Canada. He has made significant contributions to the field of cannabinoid derivatives, focusing on their pharmaceutical applications. His work has the potential to impact various therapeutic areas, particularly in the realm of cannabinoid-based treatments.

Latest Patents

Heinz Werner Pauls holds a patent for cannabinoid derivatives. This disclosure relates generally to cannabinoid derivatives, pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives. His innovative approach in this area has garnered attention for its potential benefits in medical applications.

Career Highlights

Heinz is currently associated with Canopy Growth Corporation, a leading company in the cannabis industry. His role at the company allows him to leverage his expertise in cannabinoid research and development. With a focus on advancing cannabinoid-based therapies, he continues to contribute to the evolving landscape of medicinal cannabis.

Collaborations

Heinz collaborates with Jeffrey Alan Omeara, working together to explore new avenues in cannabinoid research. Their partnership enhances the innovative efforts at Canopy Growth Corporation, driving forward the development of effective cannabinoid-based solutions.

Conclusion

Heinz Werner Pauls is a notable inventor whose work in cannabinoid derivatives is paving the way for advancements in pharmaceutical applications. His contributions are significant in the ongoing exploration of cannabinoid-based therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…